Tapering Canakinumab Monotherapy in Patients With Systemic Juvenile Idiopathic Arthritis in Clinical Remission: Results From a Phase IIIb/IV Open‐Label, Randomized Study

OBJECTIVE: To evaluate the efficacy and safety of 2 canakinumab monotherapy tapering regimens in order to maintain complete clinical remission in children with systemic juvenile idiopathic arthritis (JIA). METHODS: The study was designed as a 2‐part phase IIIb/IV open‐label, randomized trial. In the...

Descripción completa

Detalles Bibliográficos
Autores principales: Quartier, Pierre, Alexeeva, Ekaterina, Constantin, Tamàs, Chasnyk, Vyacheslav, Wulffraat, Nico, Palmblad, Karin, Wouters, Carine, I. Brunner, Hermine, Marzan, Katherine, Schneider, Rayfel, Horneff, Gerd, Martini, Alberto, Anton, Jordi, Wei, Xiaoling, Slade, Alan, Ruperto, Nicolino, Abrams, Ken
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Pediatric Rheumatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898684/
https://www.ncbi.nlm.nih.gov/pubmed/32783351
http://dx.doi.org/10.1002/art.41488

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898684/
https://www.ncbi.nlm.nih.gov/pubmed/32783351
http://dx.doi.org/10.1002/art.41488

Ejemplares similares